50 likes | 185 Views
IDEAL: Study design. . Objective: To compare intensive vs less-intensive lipid-lowering therapiesDesign: Prospective, randomized, open-label, blinded end-point evaluation ( PROBE)Population: N = 8888 with previous MITreatment: Atorvastatin 80 mg, simvastatin 20-40 mg/dPrimary
E N D